95 related articles for article (PubMed ID: 12048120)
1. Rho/Rho-kinase is involved in the synthesis of tissue factor in human monocytes.
Nagata K; Ishibashi T; Sakamoto T; Ohkawara H; Shindo J; Yokoyama K; Sugimoto K; Sakurada S; Takuwa Y; Nakamura S; Teramoto T; Maruyama Y
Atherosclerosis; 2002 Jul; 163(1):39-47. PubMed ID: 12048120
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes.
Ishibashi T; Nagata K; Ohkawara H; Sakamoto T; Yokoyama K; Shindo J; Sugimoto K; Sakurada S; Takuwa Y; Teramoto T; Maruyama Y
Biochim Biophys Acta; 2002 Jun; 1590(1-3):123-30. PubMed ID: 12063175
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitor enhances inducible nitric oxide synthase expression in rat vascular smooth muscle cells; involvement of the Rho/Rho kinase pathway.
Yamamoto T; Takeda K; Harada S; Nakata T; Azuma A; Sasaki S; Nakagawa M
Atherosclerosis; 2003 Feb; 166(2):213-22. PubMed ID: 12535733
[TBL] [Abstract][Full Text] [Related]
4. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
5. Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, inhibits cardiac myocyte hypertrophy induced by endothelin.
Nishikimi T; Tadokoro K; Wang X; Mori Y; Asakawa H; Akimoto K; Yoshihara F; Horio T; Minamino N; Matsuoka H
Eur J Pharmacol; 2002 Oct; 453(2-3):175-81. PubMed ID: 12398901
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells.
Yokoyama K; Ishibashi T; Ohkawara H; Kimura J; Matsuoka I; Sakamoto T; Nagata K; Sugimoto K; Sakurada S; Maruyama Y
Circulation; 2002 Feb; 105(8):962-7. PubMed ID: 11864926
[TBL] [Abstract][Full Text] [Related]
7. Integral role of RhoA activation in monocyte adhesion-triggered tissue factor expression in endothelial cells.
Ishibashi T; Sakamoto T; Ohkawara H; Nagata K; Sugimoto K; Sakurada S; Sugimoto N; Watanabe A; Yokoyama K; Sakamoto N; Kurabayashi M; Takuwa Y; Maruyama Y
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):681-7. PubMed ID: 12692008
[TBL] [Abstract][Full Text] [Related]
8. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.
Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF
Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957
[TBL] [Abstract][Full Text] [Related]
9. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis.
Ni W; Egashira K; Kataoka C; Kitamoto S; Koyanagi M; Inoue S; Takeshita A
Circ Res; 2001 Aug; 89(5):415-21. PubMed ID: 11532902
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
[TBL] [Abstract][Full Text] [Related]
12. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
[TBL] [Abstract][Full Text] [Related]
13. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
[TBL] [Abstract][Full Text] [Related]
14. Rho/ROCK pathway as a target of tumor therapy.
Rattan R; Giri S; Singh AK; Singh I
J Neurosci Res; 2006 Feb; 83(2):243-55. PubMed ID: 16385577
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells.
Kamiyama M; Utsunomiya K; Taniguchi K; Yokota T; Kurata H; Tajima N; Kondo K
J Atheroscler Thromb; 2003; 10(2):117-23. PubMed ID: 12740486
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
17. Rho A/Rho kinase: human umbilical artery mRNA expression in normal and pre eclamptic pregnancies and functional role in isoprostane-induced vasoconstriction.
Friel AM; Sexton DJ; O'reilly MW; Smith TJ; Morrison JJ
Reproduction; 2006 Jul; 132(1):169-76. PubMed ID: 16816342
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes.
He M; He X; Xie Q; Chen F; He S
Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627
[TBL] [Abstract][Full Text] [Related]
19. Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Med Hypotheses; 2007; 68(5):1108-13. PubMed ID: 17097823
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway.
Bea F; Puolakkainen MH; McMillen T; Hudson FN; Mackman N; Kuo CC; Campbell LA; Rosenfeld ME
Circ Res; 2003 Mar; 92(4):394-401. PubMed ID: 12600889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]